P
MRK icon

Palladiem’s Merck MRK Stock Holding History

Palladiem’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21K Hold
10
– – ﹤0.01% 144
2025
Q4 		$1.05K Buy
+10
New +$939 ﹤0.01% 157
2015
Q2 		– Sell
-2,164
Closed -$119K – 261
2015
Q1 		$119K Sell
2,164
-105
-5% -$5.95K 0.1% 33
2014
Q4 		$123K Buy
+2,269
New +$126K 0.1% 41

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Palladiem's MRK Position: Q1 2026 in Review

Palladiem held its Merck (MRK) position steady in Q1 2026 at 10 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #144.

Palladiem first reported a position in MRK in Q4 2014 and has held it in 4 quarters since. The position peaked at $123K in Q4 2014. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Palladiem held 10 shares of Merck worth $1.21K as of Q1 2026.
  • Palladiem left its Merck share count unchanged in Q1 2026.
  • Merck made up ﹤0.01% of Palladiem's portfolio in Q1 2026, its #144 holding.
  • Palladiem first reported a position in Merck in Q4 2014 and has held it in 4 quarters since.
  • Palladiem's Merck position peaked at $123K in Q4 2014.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Palladiem's 13F filing for Q1 2026, filed 6 May 2026.